Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

November 3, 2020

Conditions
Ureaplasma Infections
Interventions
DRUG

Azithromycin

Azithromycin intravenous 20 mg/kg every 24 h x 3 days

DRUG

Placebo

D5W

Trial Locations (7)

19713

Christiana Care Health Services, Newark

21201

University of Maryland School of Medicine, Baltimore

21202

Mercy Medical Center, Baltimore

21287

Johns Hopkins University, Baltimore

35249-7335

University of Alabama at Birmingham, Birmingham

37232-9544

Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville

22908-0386

University of Virginia, Charlottesville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

Mercy Medical Center

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

University of Virginia

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

Christiana Care Health Services

OTHER

lead

University of Maryland, Baltimore

OTHER